{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:53Z","timestamp":1791319853824,"version":"4.3.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"name":"Hebei Province Medical Science Research Project Plan","award":["20230100"],"award-info":[{"award-number":["20230100"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Goals:<\/jats:title>\n                    <jats:p>The study aims to analyze and project esophageal cancer trends in China from 1990 to 2023 using GBD 2023 data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Esophageal cancer (EC) remains a major public health challenge in China. Updated evidence on long-term trends and future burden is needed to inform prevention and control strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We extracted EC incidence and mortality data for China from 1990 to 2023 from the Global Burden of Disease (GBD) 2023 study. Joinpoint regression was used to characterize temporal changes and estimate annual percentage change (APC) and average annual percentage change (AAPC) in age-standardized incidence and mortality rates (ASIR\/ASMR). Autoregressive integrated moving average (ARIMA) models were applied to project rates through 2050.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 1990 to 2023, EC ASIR declined from 28.23 to 11.45 per 100,000, with an overall AAPC of \u22122.56% (95% CI: \u22123.00 to \u22122.13). ASMR decreased similarly, with an AAPC of \u22122.94% (95% CI: \u22125.36 to \u22120.47). Joinpoint analysis identified multiple trend segments, with the steepest decline in ASIR during 2007 to 2014 (APC: \u22127.00%). Notably, after a prolonged decrease, ASIR rebounded significantly during 2020 to 2023 (APC: 4.86%; 95% CI: 3.01-6.73).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Although China has markedly reduced the esophageal cancer burden since 1990, the post-2020 rebound in incidence calls for intensified surveillance and rapid evaluation of potential drivers. Priority actions include risk-stratified prevention and strengthened targeted screening for high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcg.0000000000002437","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:00:34Z","timestamp":1791316834000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050"],"prefix":"10.1097","author":[{"given":"Peng","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huisen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"R1-20261006","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20261006","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1097\/CM9.0000000000003420","article-title":"Global esophageal cancer epidemiology in 2022 and predictions for 2050: a comprehensive analysis and projections based on GLOBOCAN data","volume":"137","author":"Qi","year":"2024","journal-title":"Chin Med J"},{"key":"R3-20261006","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.34301","article-title":"Esophageal cancer in China: practice and research in the new era","volume":"152","author":"Zhu","year":"2023","journal-title":"Int J Cancer"},{"key":"R4-20261006","doi-asserted-by":"crossref","first-page":"e46051","DOI":"10.2196\/46051","article-title":"Spatiotemporal patterns of esophageal cancer burden attributable to behavioral, metabolic, and dietary risk factors from 1990 to 2019: longitudinal observational study","volume":"9","author":"Li","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"R5-20261006","first-page":"656","article-title":"Esophageal cancer global burden profiles, trends, and contributors","volume":"21","author":"Teng","year":"2024","journal-title":"Cancer Biol Med"},{"key":"R6-20261006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jncc.2023.01.002","article-title":"Patterns and trends in esophageal cancer incidence and mortality in China: an analysis based on cancer registry data","volume":"3","author":"Chen","year":"2023","journal-title":"J Natl Cancer Center"},{"key":"R7-20261006","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.20892\/j.issn.2095-3941.2022.0231","article-title":"Current cancer burden in China: epidemiology, etiology, and prevention","volume":"19","author":"Cao","year":"2022","journal-title":"Cancer Biol Med"},{"key":"R8-20261006","doi-asserted-by":"crossref","first-page":"e45360","DOI":"10.2196\/45360","article-title":"Profiles and findings of population-based esophageal cancer screening with endoscopy in China: systematic review and meta-analysis","volume":"9","author":"Li","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"R9-20261006","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.4251\/wjgo.v16.i4.1180","article-title":"Esophageal cancer screening, early detection and treatment: current insights and future directions","volume":"16","author":"Qu","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"R10-20261006","doi-asserted-by":"crossref","first-page":"04025","DOI":"10.7189\/jogh.14.04025","article-title":"Burdens of stomach and esophageal cancer from 1990 to 2019 and projection to 2030 in China: findings from the 2019 Global Burden of Disease Study","volume":"14","author":"Jiang","year":"2024","journal-title":"J Glob Health"},{"key":"R11-20261006","doi-asserted-by":"crossref","first-page":"1518567","DOI":"10.3389\/fonc.2024.1518567","article-title":"Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021","volume":"14","author":"Zhang","year":"2025","journal-title":"Front Oncol"},{"key":"R12-20261006","doi-asserted-by":"crossref","DOI":"10.18332\/tid\/191389","article-title":"Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: an analysis and comparison","volume":"22","author":"Wang","year":"2024","journal-title":"Tob Induc Dis"},{"key":"R13-20261006","doi-asserted-by":"crossref","first-page":"e48449","DOI":"10.2196\/48449","article-title":"Secular trends in gastric and esophageal cancer attributable to dietary carcinogens from 1990 to 2019 and projections until 2044 in China: population-based study","volume":"9","author":"Guo","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"R14-20261006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-024-00718-2","article-title":"Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021","volume":"13","author":"Jin","year":"2025","journal-title":"Biomark Res"},{"key":"R15-20261006","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","article-title":"Global burden of oesophageal and gastric cancer by histology and subsite in 2018","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"key":"R16-20261006","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1016\/S2468-2667(23)00242-6","article-title":"Tobacco control in China","volume":"8","author":"Chan","year":"2023","journal-title":"Lancet Public Health"},{"key":"R17-20261006","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.23.01284","article-title":"Effectiveness of endoscopic screening on esophageal cancer incidence and mortality: a 9-year report of the endoscopic screening for esophageal cancer in China (ESECC) randomized trial","volume":"42","author":"Liu","year":"2024","journal-title":"J Clin Oncol"},{"key":"R18-20261006","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1002\/cam4.6028","article-title":"Impact of the COVID-19 pandemic on cancer healthcare utilization in southwestern China to March 2021","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med"},{"key":"R19-20261006","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/j.gastro.2020.05.037","article-title":"Impacts of the coronavirus 2019 pandemic on gastrointestinal endoscopy volume and diagnosis of gastric and colorectal cancers: a population-based study","volume":"159","author":"Lui","year":"2020","journal-title":"Gastroenterology"},{"key":"R20-20261006","doi-asserted-by":"crossref","first-page":"17562848221117636","DOI":"10.1177\/17562848221117636","article-title":"The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients","volume":"15","author":"Domper-Arnal","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"R21-20261006","doi-asserted-by":"crossref","first-page":"881718","DOI":"10.3389\/fpubh.2022.881718","article-title":"Delayed diagnosis and treatment of cancer patients during the COVID-19 pandemic in Henan, China: an interrupted time series analysis","volume":"10","author":"Liu","year":"2022","journal-title":"Front Public Health"},{"key":"R22-20261006","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12672-025-02181-3","article-title":"Global trends in esophageal cancer and metabolic syndrome research: bibliometric analysis and visualization from 1995 to 2024","volume":"16","author":"Che","year":"2025","journal-title":"Discov Oncol"},{"key":"R23-20261006","doi-asserted-by":"crossref","first-page":"e1004064","DOI":"10.1371\/journal.pmed.1004064","article-title":"Trends in smoking prevalence in urban and rural China, 2007 to 2018: findings from 5 consecutive nationally representative cross-sectional surveys","volume":"19","author":"Zhang","year":"2022","journal-title":"PLoS Med"},{"key":"R24-20261006","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R25-20261006","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","article-title":"The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020","volume":"163","author":"Morgan","year":"2022","journal-title":"Gastroenterology"},{"key":"R26-20261006","doi-asserted-by":"crossref","first-page":"102201","DOI":"10.1016\/j.eclinm.2023.102201","article-title":"Long-term esophageal cancer risk and distinct surveillance intervals after a single endoscopy screening: a multicentre population-based cohort study","volume":"63","author":"Li","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCG.0000000000002437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:00:38Z","timestamp":1791316838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCG.0000000000002437"}},"subtitle":["An Analysis of the Global Burden of Disease Study 2023"],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000002437","relation":{},"ISSN":["1539-2031","0192-0790"],"issn-type":[{"value":"1539-2031","type":"electronic"},{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"2026-04-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}